Ernexa Q2 net loss widens to $4.01 million; reports no revenue - ERNA News | RalliesErnexa Q2 net loss widens to $4.01 million; reports no revenue
E
ERNA• Pipeline update
- Independently run July 2026 study reproduced earlier ERNA-101 results; IND submission targeted for Q3 2026, Phase 1 trial expected in Q4.
Q2 loss widens as expenses rise
- Ernexa posted a net loss of USD 4.01 million for the quarter ended June 30, 2026, widening from USD 3.14 million a year earlier.
- Operating loss widened to USD 4.1 million from USD 2.5 million, as operating expenses climbed 64.1% to USD 4.1 million.
- Research and development expense more than doubled to USD 2.79 million, while general and administrative expense edged down 3.88% to USD 1.31 million.
Cash position and operating cash use
- Cash totaled about USD 5 million at June 30, 2026; net cash used in operating activities rose to USD 6.42 million for the six months.
PUBM
•
